Search For "restricted emergency use"
SII's Covovax gets DCGI emergency use nod for children between 7-12 years
Updated : 3 years, 11 months ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 4 years, 1 month ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Subject Expert Panel recommends Corbevax COVID-19 vaccines for children ag
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has recommended restricted emergency use of Biological E's Corbevax COVID-19 vaccine for children aged 5-11, said sources on Thursday.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 4 years, 1 month ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
Optimus Pharma granted permission for restricted use under emergency situa
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], December 28 (ANI/PNN): Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Serum Institute seeks DCGI nod for clinical trials of COVID-19 vaccine COV
Updated : 5 years, 4 months ago IST
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Read More
Emergency use of vaccine is based on safety, immunogenicity data, says ICM
Updated : 5 years, 5 months ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
When Indian scientists do something for public welfare, Congress has probl
Updated : 5 years, 5 months ago IST
New Delhi [India], January 4 (ANI): After the drug regulator of the country gave in principle approval for restricted emergency use to two indigenously made vaccines, Bharatiya Janata Party (BJP) spokesperson Sambit Patra on Monday said that when India's scientists develop things for public
Read More
Whenever India achieves something, Cong comes up with wild theories to rid
Updated : 5 years, 5 months ago IST
New Delhi [India], January 3 (ANI): Bharatiya Janata Party (BJP) national president JP Nadda on Sunday slammed the Congress and other opposition parties for questioning India's drug regulator's approval to two COVID-19 vaccines for restricted emergency use in the country.
Read More
No need to do politics over COVID-19 vaccines: Giriraj Singh
Updated : 5 years, 5 months ago IST
New Delhi [India], January 3 (ANI): Union Minister Giriraj Singh hit out at those who are raising question over the Drugs Controller General of India's decision to give nod to two coronavirus vaccines for restricted emergency use and said that there is no need to do any politics on the ma
Read More
Recommendation for DCGI nod for restricted emergency use of two COVID-19 v
Updated : 5 years, 5 months ago IST
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Read More